-
February 21: The Week in Cancer News
A study shows that young cancer survivors have a higher death rate than their siblings in the decades following diagnosis, and a cancer survivor has a baby using immature eggs harvested prior to treatment and matured in the lab.
by Kate Yandell
-
February 14: The Week in Cancer News
A survey finds that outpatient palliative care clinics have become nearly ubiquitous in National Cancer Institute-designated cancer centers, and a group of oncology professionals calls for a cancer patient's bill of rights.
by Kate Yandell
-
February 7: The Week in Cancer News
A massive sequencing project reveals that mutations that drive cancer often occur years before the disease is diagnosed, and researchers report preliminary results from a trial for a new form of immunotherapy.
by Kate Yandell
-
January 31: The Week in Cancer News
A randomized trial shows that lung cancer screening reduces lung cancer deaths, and a study indicates that a single dose of psilocybin may have a lasting impact on cancer patients' anxiety and depression.
by Kate Yandell
-
January 24: The Week in Cancer News
A study shows that the rate of death following bone marrow transplant has decreased, and the U.S. Food and Drug Administration approves a new treatment for patients with a rare form of sarcoma.
by Kate Yandell
-
January 17: The Week in Cancer News
A study shows that eating more vegetables does not reduce risk of progression for patients with early-stage prostate cancer, and a new website provides information on cancer survival rates.
by Kate Yandell
-
January 10: The Week in Cancer News
The rate of cancer deaths in the U.S. has continued to decline, and the U.S. Food and Drug Administration approves a new treatment for a rare cancer type.
by Kate Yandell
-
January 3: The Week in Cancer News
When reading mammograms, an artificial intelligence system yields fewer false-positive and false-negative results than radiologists, and the U.S. Food and Drug Administration approves a targeted therapy for pancreatic cancer.
by Kate Yandell
-
2019: This Year in Cancer News
The Cancer Today editorial staff selects some of the most impactful and informative reporting and essays of 2019.
by Cancer Today Staff
-
Progress, But Still Room for Improvement
The winter 2019/2020 issue of Cancer Today tells the stories of people working to improve privacy protections for patients seeking support online, expand access to genetic testing and boost the efficacy of immunotherapy to benefit more patients.
by Kevin McLaughlin
Cancer Talk
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore